WEBSITE BSE:532842 NSE : SREE RAYALA 10 May, 16:01
Market Cap ₹905 Cr.
Stock P/E 6.9
P/B 1.1
Current Price ₹527.5
Book Value ₹ 488.8
Face Value 10
52W High ₹815
Dividend Yield 0.76%
52W Low ₹ 453.1
Sree Rayalaseema Hi-Strength Hypo Ltd is an totally India-based manufacture of inorganic chemical substances. The Company is engaged in manufacturing and sale of commercial chemicals and technology and distribution of power. The Company operates thru two segments: Chemicals and Power technology. The Company generates power via wind and thermal. The Company's merchandise consist of calcium hypo chlorite, solid bleaching powder (SBP), aluminium sulphate, monochloric acetic acid (MCA), sulfuric acid, chlorosulphonic acid, hydrochloric acid and oleum. The Company has 3 SBP plants, of which 2 are located at Gondiparla, Kurnool District, Andhra Pradesh, and one is placed at Manjawadi, Laxmapuram, Dharmapuri District, Tamil Nadu. The Company's sulfuric acid, chloro sulfonic acid, MCA and calcium hypochlorite (hi-strength hypo) plants are situated at Gondiparla, Kurnool District, Andhra Pradesh. Its wind mill power devices are situated in Tamil Nadu State.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 271 | 295 | 414 | 570 | 344 | 301 | 435 | 261 | 226 | 215 |
Other Income | 1 | 0 | 7 | 0 | 3 | 11 | 20 | 1 | 2 | 10 |
Total Income | 272 | 296 | 421 | 570 | 347 | 311 | 455 | 262 | 228 | 225 |
Total Expenditure | 239 | 248 | 372 | 517 | 310 | 274 | 371 | 226 | 199 | 192 |
Operating Profit | 33 | 47 | 49 | 54 | 37 | 37 | 85 | 36 | 29 | 33 |
Interest | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
Depreciation | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 3 | 3 | 3 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6 |
Profit Before Tax | 28 | 41 | 44 | 49 | 31 | 32 | 79 | 33 | 25 | 23 |
Provision for Tax | 7 | 14 | 6 | 13 | 8 | 8 | 7 | 8 | 7 | 7 |
Profit After Tax | 21 | 27 | 37 | 36 | 24 | 24 | 71 | 24 | 18 | 17 |
Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
Profit After Adjustments | 21 | 27 | 37 | 36 | 24 | 24 | 71 | 24 | 18 | 17 |
Adjusted Earnings Per Share | 12 | 15.5 | 21.7 | 20.9 | 13.8 | 13.7 | 41.4 | 14.2 | 10.8 | 9.7 |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|
Net Sales | 363 | 164 | 689 | 911 | 1267 | 1650 | 1137 |
Other Income | 4 | 0 | 4 | 7 | 11 | 35 | 33 |
Total Income | 367 | 165 | 693 | 917 | 1278 | 1685 | 1170 |
Total Expenditure | 319 | 142 | 587 | 781 | 1119 | 1470 | 988 |
Operating Profit | 48 | 22 | 106 | 137 | 159 | 215 | 183 |
Interest | 11 | 3 | 10 | 5 | 3 | 5 | 4 |
Depreciation | 10 | 10 | 50 | 51 | 19 | 19 | 14 |
Exceptional Income / Expenses | -1 | 0 | 0 | 0 | 0 | 0 | -6 |
Profit Before Tax | 25 | 9 | 45 | 81 | 137 | 190 | 160 |
Provision for Tax | 7 | -0 | 8 | 20 | 34 | 36 | 29 |
Profit After Tax | 19 | 9 | 38 | 61 | 103 | 154 | 130 |
Adjustments | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 25 | 9 | 38 | 61 | 103 | 154 | 130 |
Adjusted Earnings Per Share | 17 | 5.9 | 22.1 | 35.3 | 59.9 | 89.9 | 76.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 30% | 34% | 35% | 0% |
Operating Profit CAGR | 35% | 27% | 35% | 0% |
PAT CAGR | 50% | 59% | 52% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 7% | 23% | 28% | 38% |
ROE Average | 23% | 21% | 16% | 15% |
ROCE Average | 29% | 26% | 20% | 19% |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Shareholder's Funds | 203 | 197 | 312 | 388 | 570 | 751 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 27 | 27 | 1 | 1 | 0 | 3 |
Other Non-Current Liabilities | 27 | 33 | 17 | 7 | 6 | 4 |
Total Current Liabilities | 115 | 83 | 144 | 184 | 302 | 273 |
Total Liabilities | 372 | 340 | 473 | 579 | 878 | 1031 |
Fixed Assets | 195 | 187 | 161 | 110 | 130 | 102 |
Other Non-Current Assets | 59 | 38 | 36 | 89 | 170 | 234 |
Total Current Assets | 119 | 115 | 276 | 380 | 579 | 694 |
Total Assets | 372 | 340 | 473 | 579 | 878 | 1031 |
#(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 6 | 6 | 2 | 42 | 7 | 14 |
Cash Flow from Operating Activities | 21 | -8 | 99 | 71 | 60 | 144 |
Cash Flow from Investing Activities | -9 | -1 | -38 | -115 | -1 | -112 |
Cash Flow from Financing Activities | -12 | 11 | -22 | 10 | -51 | -20 |
Net Cash Inflow / Outflow | -0 | 2 | 40 | -35 | 7 | 13 |
Closing Cash & Cash Equivalent | 6 | 8 | 42 | 7 | 14 | 27 |
# | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 17.02 | 5.93 | 22.08 | 35.29 | 59.88 | 89.87 |
CEPS(Rs) | 19.3 | 12.97 | 51.37 | 64.77 | 71.08 | 101.14 |
DPS(Rs) | 1.5 | 1.5 | 2.5 | 3 | 3.5 | 4 |
Book NAV/Share(Rs) | 138.27 | 133.52 | 181.51 | 226.03 | 332.24 | 437.48 |
Core EBITDA Margin(%) | 11.6 | 12.97 | 14.8 | 14.31 | 11.73 | 10.9 |
EBIT Margin(%) | 9.63 | 7.04 | 8.07 | 9.48 | 11.06 | 11.82 |
Pre Tax Margin(%) | 6.68 | 5.13 | 6.59 | 8.88 | 10.81 | 11.53 |
PAT Margin (%) | 4.9 | 5.19 | 5.5 | 6.65 | 8.11 | 9.34 |
Cash Profit Margin (%) | 7.45 | 11.34 | 12.8 | 12.21 | 9.62 | 10.51 |
ROA(%) | 5.02 | 2.45 | 9.32 | 11.51 | 14.11 | 16.16 |
ROE(%) | 9.18 | 4.37 | 14.92 | 17.32 | 21.45 | 23.35 |
ROCE(%) | 12.72 | 4.2 | 17.58 | 21.41 | 26.99 | 28.87 |
Receivable days | 51.13 | 114.83 | 35.63 | 35.79 | 32.92 | 31.06 |
Inventory Days | 21.22 | 37.22 | 12.94 | 15.31 | 26.44 | 29.82 |
Payable days | 33.59 | 51.41 | 13.98 | 12.36 | 19.18 | 23.23 |
PER(x) | 3.94 | 20.81 | 3.27 | 6.7 | 7.91 | 4.58 |
Price/Book(x) | 0.48 | 0.92 | 0.4 | 1.05 | 1.43 | 0.94 |
Dividend Yield(%) | 2.24 | 1.21 | 3.46 | 1.27 | 0.74 | 0.97 |
EV/Net Sales(x) | 0.49 | 1.54 | 0.12 | 0.36 | 0.57 | 0.3 |
EV/Core EBITDA(x) | 3.72 | 11.41 | 0.78 | 2.4 | 4.51 | 2.28 |
Net Sales Growth(%) | 0 | -54.8 | 319.45 | 32.18 | 39.13 | 30.21 |
EBIT Growth(%) | 0 | -67.73 | 369.42 | 55.22 | 62.41 | 39.22 |
PAT Growth(%) | 0 | -53.26 | 334.04 | 59.79 | 69.68 | 50.08 |
EPS Growth(%) | 0 | -65.14 | 272.13 | 59.79 | 69.68 | 50.08 |
Debt/Equity(x) | 0.42 | 0.4 | 0.15 | 0.16 | 0.03 | 0.02 |
Current Ratio(x) | 1.03 | 1.38 | 1.92 | 2.07 | 1.92 | 2.54 |
Quick Ratio(x) | 0.84 | 1.23 | 1.67 | 1.85 | 1.44 | 2.08 |
Interest Cover(x) | 3.27 | 3.7 | 5.47 | 15.76 | 43.7 | 41.09 |
Total Debt/Mcap(x) | 0.86 | 0.41 | 0.37 | 0.15 | 0.02 | 0.02 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 62.09 | 62.09 | 62.09 | 62.09 | 62.09 | 62.09 | 62.09 | 62.09 | 61.84 | 61.84 |
FII | 0 | 0.2 | 0.14 | 0.71 | 0.74 | 0.59 | 0.6 | 0.63 | 0.65 | 0.57 |
DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
Public | 37.86 | 37.67 | 37.72 | 37.15 | 37.12 | 37.28 | 37.27 | 37.24 | 37.48 | 37.55 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.06 | 1.06 |
FII | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.65 | 0.65 | 0.65 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About